Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00480155 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults
A Phase 2 study of Healthy, sponsored by MedImmune.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT00480155: Completed Phase 2 study of Healthy, sponsored by MedImmune.
NCT00480155 is a Phase 2 study of Healthy that has completed, run by MedImmune. The registered enrollment target is 300 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00480155, a Phase 2 study of Healthy, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
To assess the safety of a vaccine in healthy adults prior to the release of the vaccine (FluMist®) containing it.
Conditions Studied
Interventions
- OTHER Placebo
- BIOLOGICAL Frozen FluMist®
Study Locations (3)
Florida
- Covance Daytona Beach - Daytona Beach
Oregon
- Covance Portland - Portland
Texas
- Covance Austin CRU - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00480155 record still lists
NCT00480155 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00480155 reports a single indexed study location in Florida, Oregon, Texas.
Frequently Asked Questions
What is clinical trial NCT00480155 about?
NCT00480155 is a clinical study titled "A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults". To assess the safety of a vaccine in healthy adults prior to the release of the vaccine (FluMist®) containing it.
What is the current status of trial NCT00480155?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2007-05. Estimated completion is 2007-12.
What conditions does trial NCT00480155 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00480155?
The interventions under investigation include: Placebo (OTHER), Frozen FluMist® (BIOLOGICAL).
Who is sponsoring clinical trial NCT00480155?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00480155 being conducted?
This trial has 3 study locations across Florida, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00480155's enrollment target sits among peer trials
300 77th of 1090 higher than 1,004 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Nasal Treatment for COVID-19
RECRUITING · Phase 2
-
Viral Mucosal Reprogramming
RECRUITING · Phase 2
-
Effects of an Antioxidant Supplement on Blood Vessel Health
RECRUITING · Phase 2
-
Atenolol for the Prevention of Osteoporosis (APO)
ACTIVE NOT RECRUITING · Phase 2
-
Effectiveness of Aquamin® in Mitigating Halitosis
ACTIVE NOT RECRUITING · Phase 2
-
Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia